PMC:7417114 / 567-791 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T5","span":{"begin":130,"end":137},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"ts an alluring option as they have been thoroughly vetted for safety and are more readily available for treatment of patients and testing in clinical trials. Here, we characterize more than 30 approved kinase inhibitors in t"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":209,"end":219},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"ts an alluring option as they have been thoroughly vetted for safety and are more readily available for treatment of patients and testing in clinical trials. Here, we characterize more than 30 approved kinase inhibitors in t"}

{"project":"LitCovid-PubTator","denotations":[{"id":"12","span":{"begin":117,"end":125},"obj":"Species"}],"attributes":[{"id":"A12","pred":"tao:has_database_id","subj":"12","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ts an alluring option as they have been thoroughly vetted for safety and are more readily available for treatment of patients and testing in clinical trials. Here, we characterize more than 30 approved kinase inhibitors in t"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3","span":{"begin":202,"end":219},"obj":"http://purl.obolibrary.org/obo/GO_0033673"}],"text":"ts an alluring option as they have been thoroughly vetted for safety and are more readily available for treatment of patients and testing in clinical trials. Here, we characterize more than 30 approved kinase inhibitors in t"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T12","span":{"begin":209,"end":219},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T1117","span":{"begin":209,"end":219},"obj":"CHEBI:35222;CHEBI:35222"}],"text":"ts an alluring option as they have been thoroughly vetted for safety and are more readily available for treatment of patients and testing in clinical trials. Here, we characterize more than 30 approved kinase inhibitors in t"}